Probiotics and Antimicrobial Proteins· 2026Q2
Multi-Criterion In Vitro Profiling of Probiotic Strains for Preliminary Gut–Skin-Axis-Oriented Candidate Prioritization
- 1citations
- Q2SCImago
- 2026year
Short summary
A multi-criterion in vitro screening identified Lacticaseibacillus rhamnosus SCN01 and Limosilactobacillus fermentum LF160 as top probiotic candidates for the gut-skin axis, based on broad antimicrobial activity, distinct metabolic profiles, and epithelial barrier enhancement.
AI-generated from the title and abstract; the full text is not read.
Key points
- Lacticaseibacillus rhamnosus SCN01 and Limosilactobacillus fermentum LF160 showed the broadest antimicrobial activity against skin pathobionts like S. aureus and C. spp.
- Metabolomics revealed distinct extracellular signatures, with L. fermentum LF160 showing an arginine-to-ornithine/citrulline shift and high succinate.
- L. rhamnosus SCN01 significantly increased transepithelial electrical resistance (TEER) in Caco-2 cells, indicating enhanced epithelial barrier function.
- The study provides a transparent framework for preliminary in vitro prioritization of probiotic candidates targeting the gut-skin axis.
AI-generated from the title and abstract; the full text is not read.
Abstract
The gut-skin axis is a promising target for oral probiotics, yet strain choice is often empirical, rather than aligned to defined, skin-relevant functional readouts. Here, we performed a predefined multi-criterion in vitro screening of lactobacilli and bifidobacteria to prioritize candidate strains for gut-skin-axis-oriented development. The screening combined four complementary readouts: antagonistic activity against selected skin-associated pathobionts, targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) profiling of metabolites in cell-free supernatants (CFS), a simple surface-binding assay based on binding to polystyrene, and transepithelial electrical resistance (TEER) monitoring in Caco-2 intestinal epithelial monolayers during early monolayer maturation. Antimicrobial activity was strongly strain dependent and most pronounced against Staphylococcus aureus and Cutibacterium spp., with Lacticaseibacillus rhamnosus SCN01 and Limosilactobacillus fermentum LF160 showing the broadest inhibition profiles. Replicated metabolomics revealed distinct, reproducible extracellular signatures: lactate dominated across lactobacilli, B. breve SCN03 showed the clearest acetate increase, and L. fermentum LF160 displayed a coordinated arginine-to-ornithine/citrulline shift with high succinate. Nicotinic acid (vitamin B3) accumulated most in Lactobacillus acidophilus LA120 and B. breve SCN03, whereas pyridoxal (vitamin B6) and GABA were most enriched in L. plantarum SCN02; in the shortlisted strains, selected biogenic amines remained low in the replicated targeted panel. Functionally, L. rhamnosus SCN01 produced the strongest sustained TEER increase without detectable changes in cellular metabolic activity. Collectively, these data support a transparent, hypothesis-generating framework for preliminary in vitro prioritization of oral probiotic candidates with complementary antimicrobial, metabolic, surface-binding and epithelial-resistance-associated profiles. Further mechanistic, community-based, skin-cell, preclinical and clinical studies will be required to determine whether these in vitro profiles translate into gut-skin-axis-relevant benefits.
The authors' abstract, as published at the source. Probiotics and Antimicrobial Proteins, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Food Science
Food ScienceAgricultural and Biological Sciences